|
Greetings,
The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules is now open. The proposed rules include significant increases to all fees and elimination of reduced fees.
To share your feedback, please participate in the 21-day public comment period beginning today, September 1, 2026, and running through September 21, 2026 (closing at 5:00 p.m. Pacific Time).
During the public comment period, you can e-mail your comments in writing to: publichealth.rules@odhsoha.oregon.gov.
You can also share your comments by participating in one of two virtual public hearings:
2026 Annual Public Hearings
Tuesday, September 15, 2026, 6:00 PM-7:30 PM (Pacific Time)
If you plan to comment at this hearing, please sign-up in advance with this Virtual Sign-Up Sheet for Tuesday, September 15.
Zoom meeting information: Zoom Meeting Link Call in: 1-669-254-5252 (US) Meeting ID: 161 416 1945 Passcode: 372792
Wednesday, September 16, 2026, Noon - 1:30 PM (Pacific Time)
If you plan to comment at this hearing, please sign-up in advance with this Virtual Sign-Up Sheet for Wednesday, September 16.
Zoom meeting information: Zoom Meeting Link 1-669-254-5252 Meeting ID: 160 279 6776 Passcode: 767758
|
Although it is not required, if you plan to provide a comment during a public hearing we invite you to use the virtual sign-up sheets to sign-up in advance.
OPS welcomes all participants. Spanish interpretation, American Sign Language interpretation, and live transcript / CART captioning services will be provided at the hearings. If you have any questions about accommodations or need any assistance to participate please contact the Oregon Psilocybin Services team at 971-341-1713, 711 TTY, or OHA.Psilocybin@oha.oregon.gov. Every effort will be made to provide services to requests received at least 48 hours in advance, however submitting your request as early as possible is greatly appreciated.
More information about the public comment period can be found on the OPS Administrative Rules page.
Thank you, The Medical Cannabis & Psilocybin (MCAP) Section
|